✦ LIBER ✦

THE ESTROFA-LM REGISTRY: COMPARISON OF PACLITAXEL-ELUTING STENTS AND EVEROLIMUS-ELUTING STENTS IN LEFT MAIN CORONARY ARTERY DISEASE. RESULTS AT 3 YEARS FOLLOW-UP

✍ Scribed by Jose de la Torre Hernandez; Angel Sanchez-Recalde; Bruno Garcia del Blanco; Manuel Jimenez Navarro; Federico Gimeno; Ramon Calvino; Neus Salvatella; Tamara Garcia Camarero; Felipe Hernandez; Fernando Rivero; Jose Moreu; Jose R. Rumoroso; Francisco Bosa; Monica Masotti; Victoria Martin; Juan A. Bullones; Arsenio Gallardo; Jose A. Fernandez Diaz; Victor Aragon

Book ID: 118582110
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 105 KB
Volume: 59
Category: Article
ISSN: 1558-3597
DOI: 10.1016/s0735-1097(12)60298-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

THE ESTROFA-MI REGISTRY: COMPARISON OF P

THE ESTROFA-MI REGISTRY: COMPARISON OF PACLITAXEL-ELUTING STENT AND EVEROLIMUS-ELUTING STENT IN ST-ELEVATION MYOCARDIAL INFARCTION. RESULTS AT 2 YEARS FOLLOW-UP

✍ Jose de la Torre Hernandez; Victoria Martin; Manuel Jimenez Navarrro; Bruno Garc 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 105 KB

TCT-45: The ESTROFA-LM Registry: Compari

TCT-45: The ESTROFA-LM Registry: Comparison of Taxus and Xience Stents in Left Main Coronary Artery Disease. Preliminary Results at 3 Years Follow-up

📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 113 KB

TCT-262: Comparison of Efficacy and Four

TCT-262: Comparison of Efficacy and Four-Year Durability between Sirolimus-Eluting Stent and Paclitaxel-Eluting Stent in Unprotected Left Main Coronary Arteries: Multicenter Registry in Asia

📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 194 KB

TCT-30: Drug-Eluting Stents for the Trea

TCT-30: Drug-Eluting Stents for the Treatment of Left Main coronary Artery Disease with Sirolimus, Paclitaxel, Zotarolimus, BiolimusA9, EPC Capture and Everolimus-Elutting Stent: Multicenter Registry in Asia

📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 148 KB

Improved Late Clinical Safety With Zotar

Improved Late Clinical Safety With Zotarolimus-Eluting Stents Compared With Paclitaxel-Eluting Stents in Patients With De Novo Coronary Lesions: 3-Year Follow-Up From the ENDEAVOR IV (Randomized Comparison of Zotarolimus- and Paclitaxel-Eluting Stents in Patients With Coronary Artery Disease) Trial

✍ Martin B. Leon; Eugenia Nikolsky; Donald E. Cutlip; Laura Mauri; Henry Liberman; 📂 Article 📅 2010 🏛 American College of Cardiology 🌐 English ⚖ 557 KB

Sirolimus- vs. paclitaxel-eluting stents

Sirolimus- vs. paclitaxel-eluting stents for the treatment of unprotected left main coronary artery stenosis: Complete 2-year follow-up of a two-center registry

✍ Kyung Woo Park; Si-Hyuck Kang; Keun-Ho Park; Dong-Hyun Choi; Hae-Young Lee; Hyun 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 455 KB